Mitochondrial toxins in models of neurodegenerative diseases. I: In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions.
about
Cellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disordersNeuronal death is an active, caspase-dependent process after moderate but not severe DNA damage.Protective effect of α-lipoic acid against antimycin A cytotoxicity in MC3T3-E1 osteoblastic cellsPyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expressionEndogenous 3,4-dihydroxyphenylalanine and dopaquinone modifications on protein tyrosine: links to mitochondrially derived oxidative stress via hydroxyl radicalMutations in cytochrome c oxidase subunit VIa cause neurodegeneration and motor dysfunction in DrosophilaMechanism of oxidative stress in neurodegeneration.Imaging of superoxide generation in the dopaminergic area of the brain in Parkinson's disease, using mito-TEMPO.Calcium and cell death signaling in neurodegeneration and aging.Glucose Levels in Culture Medium Determine Cell Death Mode in MPP(+)-treated Dopaminergic Neuronal Cells.Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells.Paeoniflorin isolated from Paeonia lactiflora attenuates osteoblast cytotoxicity induced by antimycin A.Overexpression of CYP2D6 attenuates the toxicity of MPP+ in actively dividing and differentiated PC12 cells.Mitochondria As Sources and Targets of Methane.Honokiol protects osteoblastic MC3T3-E1 cells against antimycin A-induced cytotoxicity.
P2860
Q28754228-5D1BABEA-9502-4FA3-B2CA-B768EDDA3CDFQ32034942-3B0A787C-41ED-4975-9DAC-6D93018C1995Q32186920-E2E6899F-5224-4959-84B9-CA1163CAAE08Q33581174-81F8BC44-BCDC-48EF-BE1C-5975EDA1E086Q33883022-4A7B41D4-3757-4FAE-A4F8-9CBDE45D9B0DQ35846393-6E5CB1D0-4A9B-4994-8EE3-FD997DB34A22Q35996874-CBDD3909-C163-4376-8CDC-7D59F6C2AF67Q37334372-3D70E00E-755F-4611-A44A-C390A2A51556Q37590186-C9D4B9D7-ECEA-4EDE-A220-2CEE6BF1CC04Q42161145-FE6D45CF-846D-47FF-8EFC-1FB9EB0EC434Q42490786-7999326C-6170-4E59-B86D-A61F783A0C0EQ42817098-90B2C14E-1DD8-4BC1-9ADE-DAB8493F82D0Q44700084-34B094A4-CD85-4E70-92EE-B80A914EDD7AQ47155471-83CCDC8C-46D9-434E-886F-262A61619256Q54571045-2B41AF6E-DBF6-41BE-9CF7-962619BCA9B6
P2860
Mitochondrial toxins in models of neurodegenerative diseases. I: In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions.
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Mitochondrial toxins in models ...... ethylpyridinium or azide ions.
@ast
Mitochondrial toxins in models ...... ethylpyridinium or azide ions.
@en
type
label
Mitochondrial toxins in models ...... ethylpyridinium or azide ions.
@ast
Mitochondrial toxins in models ...... ethylpyridinium or azide ions.
@en
prefLabel
Mitochondrial toxins in models ...... ethylpyridinium or azide ions.
@ast
Mitochondrial toxins in models ...... ethylpyridinium or azide ions.
@en
P1433
P1476
Mitochondrial toxins in models ...... ethylpyridinium or azide ions.
@en
P2093
Bennett JP Jr
P304
P356
10.1016/S0006-8993(97)00429-0
P407
P577
1997-08-01T00:00:00Z